These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 12399878)

  • 21. Systemic lupus erythematosus.
    Madhok R; Wu O
    Am Fam Physician; 2007 Nov; 76(9):1351-3. PubMed ID: 18019880
    [No Abstract]   [Full Text] [Related]  

  • 22. A unilateral erosive arthritis in a patient with systemic lupus erythematosus.
    Scherlinger M; Schaeverbeke T; Blanco P; Richez C
    Joint Bone Spine; 2017 Mar; 84(2):245-246. PubMed ID: 27269652
    [No Abstract]   [Full Text] [Related]  

  • 23. Coronary artery bypass grafting in patients with systemic lupus erythematosus.
    Bossert T; Falk V; Gummert JF; Rahmel A; Mohr FW
    Z Kardiol; 2003 Mar; 92(3):219-21. PubMed ID: 12658468
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Frequency of adverse drug reactions in patients with systemic lupus erythematosus.
    Pope J; Jerome D; Fenlon D; Krizova A; Ouimet J
    J Rheumatol; 2003 Mar; 30(3):480-4. PubMed ID: 12610805
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Childhood hermolytic uremic syndrome associated with systemic lupus erythematosus.
    Wu CY; Su YT; Wang JS; Chiou YH
    Lupus; 2007; 16(12):1006-10. PubMed ID: 18042599
    [No Abstract]   [Full Text] [Related]  

  • 26. Rituximab in lupus and beyond: the state of the art.
    Hughes G
    Lupus; 2009 Jun; 18(7):639-44. PubMed ID: 19433465
    [No Abstract]   [Full Text] [Related]  

  • 27. Outcome of protein-losing gastroenteropathy in systemic lupus erythematosus treated with prednisolone and azathioprine.
    Mok CC; Ying KY; Mak A; To CH; Szeto ML
    Rheumatology (Oxford); 2006 Apr; 45(4):425-9. PubMed ID: 16234272
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multiple myeloma and systemic lupus erythematosus in a young woman.
    Okoli K; Irani F; Horvath W
    J Clin Rheumatol; 2009 Sep; 15(6):292-4. PubMed ID: 19734735
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk factors for thrombosis and primary thrombosis prevention in patients with systemic lupus erythematosus with or without antiphospholipid antibodies.
    Tektonidou MG; Laskari K; Panagiotakos DB; Moutsopoulos HM
    Arthritis Rheum; 2009 Jan; 61(1):29-36. PubMed ID: 19116963
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Role of gonadotropin releasing hormone analogues for ovarian protection in systemic lupus erythematosus patients treated with cyclophosphamide].
    Liang LQ; Qiu Q; Yang XY; Xu HS; Ye YJ; Zhan ZP; Lian F; Chen DY
    Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(15):1009-11. PubMed ID: 18754430
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The egg and I: preserving fertility in systemic lupus erythematosus.
    Petri M
    Lupus; 2000; 9(6):399-400. PubMed ID: 10981641
    [No Abstract]   [Full Text] [Related]  

  • 32. The influence of the 1997 updated classification criteria for systemic lupus erythematosus: epidemiology, disease presentation, and patient management.
    Eilertsen GØ; Becker-Merok A; Nossent JC
    J Rheumatol; 2009 Mar; 36(3):552-9. PubMed ID: 19208593
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tolerance and short term efficacy of rituximab in 43 patients with systemic autoimmune diseases.
    Gottenberg JE; Guillevin L; Lambotte O; Combe B; Allanore Y; Cantagrel A; Larroche C; Soubrier M; Bouillet L; Dougados M; Fain O; Farge D; Kyndt X; Lortholary O; Masson C; Moura B; Remy P; Thomas T; Wendling D; Anaya JM; Sibilia J; Mariette X;
    Ann Rheum Dis; 2005 Jun; 64(6):913-20. PubMed ID: 15550531
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome.
    Tektonidou MG; Sotsiou F; Nakopoulou L; Vlachoyiannopoulos PG; Moutsopoulos HM
    Arthritis Rheum; 2004 Aug; 50(8):2569-79. PubMed ID: 15334471
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical and laboratory characteristics and long-term outcome of pediatric systemic lupus erythematosus: a longitudinal study.
    Hiraki LT; Benseler SM; Tyrrell PN; Hebert D; Harvey E; Silverman ED
    J Pediatr; 2008 Apr; 152(4):550-6. PubMed ID: 18346514
    [TBL] [Abstract][Full Text] [Related]  

  • 36. EULAR points to consider for conducting clinical trials in systemic lupus erythematosus.
    Gordon C; Bertsias G; Ioannidis JP; Boletis J; Bombardieri S; Cervera R; Dostál C; Font J; Gilboe IM; Houssiau F; Huizinga TW; Isenberg D; Kallenberg CG; Khamashta MA; Piette JC; Schneider M; Smolen JS; Sturfelt G; Tincani A; Van Vollenhoven R; Boumpas DT
    Ann Rheum Dis; 2009 Apr; 68(4):470-6. PubMed ID: 18388158
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chylothorax as the initial presentation of systemic lupus erythematosus: a case report.
    Lin YJ; Chen DY; Lan JL; Hsieh TY
    Clin Rheumatol; 2007 Aug; 26(8):1373-4. PubMed ID: 16927041
    [No Abstract]   [Full Text] [Related]  

  • 38. Greater accrual damage in late-onset systemic lupus erythematosus: a long-term follow-up study.
    Appenzeller S; Pereira DA; Costallat LT
    Lupus; 2008 Nov; 17(11):1023-8. PubMed ID: 18852227
    [TBL] [Abstract][Full Text] [Related]  

  • 39. B cell depletion therapy in systemic lupus erythematosus: relationships among serum B lymphocyte stimulator levels, autoantibody profile and clinical response.
    Cambridge G; Isenberg DA; Edwards JC; Leandro MJ; Migone TS; Teodorescu M; Stohl W
    Ann Rheum Dis; 2008 Jul; 67(7):1011-6. PubMed ID: 17962238
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Ecchymotic angioedema revealing childhood systemic lupus erythematosus with anti-C1q antibodies].
    Frot AS; Barbarot S; Poignant S; Guyot C; Stalder JF
    Ann Dermatol Venereol; 2008; 135(8-9):584-6. PubMed ID: 18789294
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.